NovoRapid®

References

  1. Heller S, Colagiuri S, Vaaler S et al. Hypoglycaemia with insulin aspart: a double-blind, randomised, crossover trial in subjects with type 1 diabetes. Diabet Med 2004; 21(7): 769–775.
  2. Amiel S, Home PD, Jacobsen JL et al. Insulin aspart safe for long-term treatment.
    Diabetologia 2001; 44(Suppl 1): A209.
  3. Hermansen K, Fontaine P, Kukolja KK et al. Insulin analogues (insulin detemir and insulin aspart) versus traditional human insulins (NPH insulin and regular human insulin) in basal–bolus therapy for patients with type 1 diabetes. Diabetologia 2004; 47(4): 622–629.
  4. Raslová K, Bogoev M, Raz I. Insulin detemir and insulin aspart: a promising basal–bolus regimen for type 2 diabetes. Diabetes Res Clin Pract 2004; 66(2): 193–201.
  5. Bretzel RG, Arnold S, Medding J et al. A direct ef?cacy and safety comparison of insulin aspart, human soluble insulin, and human premix insulin (70/30) in patients with type 2 diabetes.
  6. Brunner GA, Hirschberger S, Sendlhofer G et al. Post-prandial administration of the insulin analogue insulin aspart in patients with type 1 diabetes mellitus. Diabet Med 2000;17(5): 371–375.
  7. Danne T, Aman J, Schober E et al. A comparison of postprandial and pre-prandial administration of insulin aspart in children and adolescents with type 1 diabetes. Diabetes Care 2003; 26: 2359–2384.
  8. Asakura T, Seino H. A comparison of the usability of two types of disposable pen (FlexPen® versus Humalog® Kit) containing rapid-acting insulin analogues. Diabetes 2003; 52(Suppl. 1): A102.
  9. Home PD, Lindholm A, Riis A. Insulin aspart vs human insulin in the management of long-term blood glucose control in Type 1 diabetes mellitus: a randomised controlled trial. Diabetes Med 2000; 17: 762–770.
  10. Raskin P, Guthrie RA, Leiter L et al. Use of insulin aspart, a fast-acting insulin analog, as the mealtime insulin in the management of patients with type 1 diabetes. Diabetes Care 2000; 23: 583–588.
  11. Perriello G, Pampanelli S, Porcellati F et al. Insulin aspart improves meal time glycaemic control in patients with Type 2 diabetes: a randomized, strati?ed, double-blind and cross-over trial. Diabet Med 2005; 22(5): 606–11.
  12. de Boer H, Jansen M, Koerts J et al. Prevention of weight gain in type 2 diabetes requiring insulin treatment. Diabetes Obes Metab. 2004; 6(2): 114–119.
  13. Poulsen MK, Henriksen JE, Hother-Nielsen O et al. The combined effect of triple therapy with rosiglitazone, metformin, and insulin aspart in type 2 diabetic patients. Diabetes Care 2003; 26(12): 3273–3279. 
  14. Data on ?le, Novo Nordisk.
  15. Danne T, Odendahl R, Naeke A et al. Postprandial insulin aspart is preferred to preprandial human insulin by parents of preschool children with type 1 diabetes. Diabetes 2005; 54(Suppl.1): A665.
  16. Jovanovic L, Pettitt DJ, Acquistapace M. Postprandial glycemic control is provided by either preprandial or postprandial administration of insulin aspart in type 1 diabetes. Diabetes 2002; 51(Suppl1 2): A102.
  17. NovoRapid® SPC, February 2005
  18. Lawton S, Berg B. Comparative evaluation of FlexPen™, a new penfilled insulin
    delivery system, among patients and healthcare professionals. Diabetes 2001; 50(Suppl 2): A440.
  19. Vora JP, Nygaard-Pedersen L, Erichsen K et al. Patients with type 2 diabetes prefer using NovoMix® 30 FlexPen™ than Humalog Mix25™ Pen for adminstration of biphasic insulin analogue. Diabetes 2002; 51(Suppl 2): A135.
Please Log in
Free registration to access disease diagnosis, patient management, physician tools.

Only registered users have access to this content.

Already Registered?

Email    Password   

Not a member?

Don't worry, registration is quick and FREE! We welcome all Healthcare professionals, doctors, nurses and medical students. 

Register today to have full access to a wealth of drug data, educational and evidence based interactive guides across all major theraputic areas, disease management, and clinical tools.

As a practicing Healthcare professional, you can also opt-in to join our market research panel – www.epgsurvey.com – and get paid for sharing your expert clinical opinions!

REGISTER today it only takes a minute! and it's FREE

Having problems?

Use our forgotten password facility or email us at: contact@epgonline.org

Exit Log in